Human coronavirus OC43-elicited CD4+ T cells shield towards SARS-CoV-2 in HLA transgenic mice – Nature Communications
PressNewsAgency,
Noh, J. Y., Jeong, H. W.
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
BioTech Gate,
PRESS RELEASE First detailed, empirical analysis of Class 1 epitopes presented by SARS-Cov-2 infected cells which define the T-Ce…
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
TMCnet.com,
] PRESS RELEASE First detailed, empirical analysis of Class 1 epitopes presented by SARS-Cov-2 infected cells which define the T…
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
Benzinga,
PRESS RELEASE First detailed, empirical analysis of Class 1 epitopes presented by SARS-Cov-2 infected cells which define the T-Ce…
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
Yahoo! Finance USA,
PRESS RELEASE First detailed, empirical analysis of Class 1 epitopes presented by SARS-Cov-2 infected cells which define the T-Ce…
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
Jotup,
During the collaboration researchers at GMU grew SARS-Cov-2, the virus which causes COVID-19, in human cells expressing ACE-2…
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
Biz Wire Express,
PRESS RELEASE First detailed, empirical analysis of Class 1 epitopes presented by SARS-Cov-2 infected cells which define the T-Ce…
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
One News Page,
PRESS RELEASE * * · First detailed, empirical analysis of Class 1 epitopes presented by SARS-Cov-2 infected cells which define…
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
One News Page,
PRESS RELEASE * * · First detailed, empirical analysis of Class 1 epitopes presented by SARS-Cov-2 infected cells which define…
News story from Finanz Nachrichten on Tuesday 15 September 2020
Finanz Nachrichten,
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
MarketScreener,
PRESS RELEASE First detailed, empirical analysis of Class 1 epitopes presented by SARS-Cov-2 infected cells which define the T-Ce…
Emergex Vaccines and George Mason University Identify T-Cell Epitopes Presented by SARS-Cov-2 Infected Cells
GlobeNewswire,
PRESS RELEASE First detailed, empirical analysis of Class 1 epitopes presented by SARS-Cov-2 infected cells which define the T-Ce…
Animal testing isn't our only option — NIH needs to invest in alternatives
MSN,
As the COVID-19 pandemic pushes 25 million cases worldwide and 6 million cases in the United States, researchers, clinicians…
Animal testing isn't our only option — NIH needs to invest in alternatives
The Hill,
As the COVID-19 pandemic pushes 25 million cases worldwide and 6 million cases in the United States, researchers, clinicians…
Modeling harmony: learning from preclinical coordination of COVID-19 countermeasures
BioCentury,
The all-hands-on-deck COVID-19 response provides a glimpse of what’s possible when drug developers converge around solving a…
Method to convert any mouse into COVID-19 model made available to researchers
Drug Target Review,
Researchers who reported that delivering the human ACE2 protein into mouse airway cells creates COVID-19 models have released…
Off-the-shelf tool for making mouse models of COVID-19.
infosurhoy,
Until there are effective treatments or vaccines, the COVID-19 pandemic will remain a significant threat to public health and…
Researchers develop a simple tool for making mouse models of COVID-19
The Medical News,
Until there are effective treatments or vaccines, the COVID-19 pandemic will remain a significant threat to public health and…
Off-the-shelf tool for making mouse models of COVID-19
MedicalXpress,
Until there are effective treatments or vaccines, the COVID-19 pandemic will remain a significant threat to public health and…
News story from Global Times (China) on Friday 12 June 2020
Global Times (China),
China’s inactivated COVID-19 vaccine protects animals from coronavirus
Timesnownews.com,
(Image credit: Xinhua)
Does China Have A Coronavirus Vaccine? Expert Says One Could Be Available Within Months
International Business Times,
KEY POINTS A Harvard University analysis indicates the virus may have started circulating in China in August, months earlier…